Wide Ranks

ARTL

Artelo Biosciences, Inc.

1.03

Top Statistics
Market Cap 3 M Forward PE -2.15 Revenue Growth 0.00 %
Current Ratio 6.56 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 5 M Total Cash Per Share 1.74 Total Debt 120000
Total Debt To Equity 1.64 Current Ratio 6.56 Book Value Per Share 3.69
All Measures
Short Ratio 165.00 % Message Board Id finmb_274120655 Shares Short Prior Month 33259
Return On Equity -0.8858 City Solana Beach Uuid f3ba8d6d-cd41-3b55-b7aa-d9f9e6994cce
Previous Close 1.10 First Trade Date Epoch Utc 1 B Book Value 3.69
Beta 1.35 Total Debt 120000 Volume 50995
Price To Book 0.2795 Last Split Date 1 B Fifty Two Week Low 1.00
Total Cash Per Share 1.74 Shares Short Previous Month Date 1 B Target Median Price 5.00
Max Age 86400 Recommendation Mean 1.67 Sand P52 Week Change 0.3133
Target Mean Price 5.33 Net Income To Common -10438000 Short Percent Of Float 0.0062
Implied Shares Outstanding 3 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 42450 Average Volume10days 42450 Total Cash 5 M
Next Fiscal Year End 1 B Held Percent Insiders 0.0083 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 1.10
Target Low Price 5.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 1.14
Open 1.07 Free Cashflow -5614875 State CA
Dividend Yield 0.00 % Return On Assets -0.5433 Time Zone Short Name EST
Trailing Eps -2.87 Day Low 1.02 Address1 505 Lomas Santa Fe
Shares Outstanding 3 M Price Hint 4 Target High Price 6.00
Website https://www.artelobio.com 52 Week Change -0.2536 Average Volume 17212
Forward Eps -0.8800 Recommendation Key buy Compensation As Of Epoch Date 1 B
Quick Ratio 596.00 % Last Split Factor 1:15 Regular Market Day High 1.09
Is_sp_500 False Profit Margins 0.00 % Debt To Equity 1.64
Fifty Two Week High 1.75 Day High 1.09 Shares Short 19925
Regular Market Open 1.07 Industry Key biotechnology Earnings Growth 0.00 %
Revenue Growth 0.00 % Shares Percent Shares Out 0.0062 Operating Cashflow -9403000
Currency USD Time Zone Full Name America/New_York Market Cap 3 M
Is_nasdaq_100 False Zip 92075 Quote Type EQUITY
Industry Biotechnology Long Name Artelo Biosciences, Inc. Regular Market Day Low 1.02
Held Percent Institutions 0.0072 Current Price 1.03 Address2 Suite 160
Financial Currency USD Current Ratio 6.56 Industry Disp Biotechnology
Number Of Analyst Opinions 3 Country United States Float Shares 3 M
Two Hundred Day Average 1.32 Enterprise Value -1705591 Forward PE -2.15
Regular Market Volume 50995 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States.

It's product candidate pipeline includes ART27.

13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.

11, a synthetic cannabidiol cocrystal for the treatment anxiety, post-traumatic stress disorder, epilepsy, inflammatory bowel disease, and other potential indications; and ART26.

12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders.

The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017.

Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.